SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the clinical trial plan of its...
Search results for "FDA"
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial
Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its next-generation targeted cancer therapy...
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
Reaching Beyond Hospitals: Wontech Targets Global Home Beauty Market for Next Growth Engine
Medical aesthetic device manufacturer Wontech is expanding beyond its traditional hospital- and clinic-centered B2B...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Robot-Assisted Operations Account for 1 in 5 Stomach Cancer Surgeries at Samsung Medical Center as Milestone Hits 1,500
Samsung Medical Center has performed more than 1,500 robot-assisted stomach cancer surgeries, reaching the milestone 16...
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization
Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
Samsung Medical Center Adopts Next-Generation Da Vinci 5 Robot to Advance Lung and Esophageal Cancer Surgery
Samsung Medical Center has introduced the latest robot-assisted surgery platform, the Da Vinci 5, for lung and...
Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries
Daewoong Pharmaceutical’s botulinum toxin product Nabota has entered Kuwait, expanding its Middle East footprint to...